TriSalus Life Sciences (TLSI) Asset Utilization Ratio (2023 - 2026)

TriSalus Life Sciences' Asset Utilization Ratio history runs 4 years deep, the most recent figure standing at 0.84 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio fell 30.91% year-over-year to 0.84 in Q1 2026; TTM through Mar 2026 was 0.84, a 30.91% decrease from a year earlier, with the FY2025 full-year figure at 1.52, up 25.65% from the prior year.
• Asset Utilization Ratio retreated to 0.84 in Q1 2026 per TLSI's latest filing, from 1.26 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 1.26 in Q4 2025 and bottomed at 0.64 in Q4 2023.
• The 4-year median for Asset Utilization Ratio is 1.01 (2024), against an average of 0.97.
• Across the five-year window, Asset Utilization Ratio jumped 79.72% in 2024 and sank 30.91% in 2026, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.64 in 2023, then soared by 79.72% to 1.14 in 2024, then climbed by 9.94% to 1.26 in 2025, then plunged by 32.87% to 0.84 in 2026.
• Per Business Quant, the three latest TLSI Asset Utilization Ratio figures stand at 0.84 (Q1 2026), 1.26 (Q4 2025), and 1.03 (Q3 2025).